InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ARS Pharmaceuticals, Inc.

SPRY Clue Score36
United States Fiscal year ends December CIK 0001671858 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

23
Insider
Date
Role
Action
Shares
Price
Amount
James E Flynn
27 Jun 2025
10% owner
Sell indirect
370,074
$18.46
$6.83M
James E Flynn
27 Jun 2025
10% owner
Sell indirect
370,075
$18.46
$6.83M
Justin Chakma
27 Nov 2024
Chief Business Officer
Sell
25,000
$14.39
$359.75K
Justin Chakma
26 Nov 2024
Chief Business Officer
Sell
42,186
$14.05
$592.57K
Justin Chakma
25 Nov 2024
Chief Business Officer
Sell
32,814
$14.00
$459.42K
James E Flynn
12 Nov 2024
10% owner
Sell indirect
9,553
$17.77
$169.76K
James E Flynn
12 Nov 2024
10% owner
Sell indirect
9,554
$17.77
$169.77K
James E Flynn
12 Nov 2024
10% owner
Sell indirect
7,854
$17.16
$134.77K
James E Flynn
12 Nov 2024
10% owner
Sell indirect
7,853
$17.16
$134.76K
James E Flynn
11 Nov 2024
10% owner
Sell indirect
223,632
$18.15
$4.06M
James E Flynn
11 Nov 2024
10% owner
Sell indirect
223,632
$18.15
$4.06M
James E Flynn
11 Nov 2024
10% owner
Sell indirect
40,596
$17.45
$708.40K
James E Flynn
11 Nov 2024
10% owner
Sell indirect
40,596
$17.45
$708.40K
Orbimed Advisors LLC
26 Aug 2024
Director
Sell indirect
83,695
$13.00
$1.09M
Peter A. Thompson
26 Aug 2024
Director
Sell indirect
83,695
$13.00
$1.09M
Orbimed Advisors LLC
23 Aug 2024
Director
Sell indirect
69,500
$13.03
$905.59K
Peter A. Thompson
23 Aug 2024
Director
Sell indirect
69,500
$13.03
$905.59K
Orbimed Advisors LLC
22 Aug 2024
Director
Sell indirect
391,482
$12.94
$5.07M
Peter A. Thompson
22 Aug 2024
Director
Sell indirect
391,482
$12.94
$5.07M
Orbimed Advisors LLC
21 Aug 2024
Director
Sell indirect
13,300
$14.61
$194.31K
Orbimed Advisors LLC
21 Aug 2024
Director
Sell indirect
394,400
$13.52
$5.33M
Peter A. Thompson
21 Aug 2024
Director
Sell indirect
13,300
$14.61
$194.31K
Peter A. Thompson
21 Aug 2024
Director
Sell indirect
394,400
$13.52
$5.33M
Showing 250 of 261 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 231
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 17
Sales on a Rule 10b5-1 plan 149
Sales straight out of an exercise 51
Sales at will 23
Transactions with no price 0
Shares from compensation/vesting 84,407,624
History held since 7 Dec 2020